506879 — Gujarat Themis Biosyn Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹33.90bn
- IN₹33.76bn
- IN₹1.70bn
Annual cashflow statement for Gujarat Themis Biosyn, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 313 | 409 | 590 | 775 | 793 |
| Depreciation | |||||
| Non-Cash Items | -7.12 | -19.7 | -20.7 | -50.1 | -36 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -313 | -301 | -189 | -355 | -156 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6.31 | 105 | 403 | 395 | 642 |
| Capital Expenditures | -32.4 | -30.6 | -139 | -237 | -746 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.55 | 8.06 | -159 | 32.9 | 194 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -29.8 | -22.5 | -298 | -204 | -552 |
| Financing Cash Flow Items | -3.19 | -4.5 | -2.05 | -1.11 | -0.894 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 21 | -51.6 | -140 | -133 | -85.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.57 | 31.1 | -35.1 | 57.9 | 4.14 |